Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease

被引：29

作者：

de Oliveira, Rodrigo Carlos ^{[1
]}

Wilson, Steven E. ^{[1
]}

机构：

[1] Cleveland Clin, Cole Eye Inst, 1-32,9500 Euclid Ave, Cleveland, OH 44106 USA

来源：

CLINICAL OPHTHALMOLOGY | 2019年 / 13卷

基金：

美国国家卫生研究院;

关键词：

keratoconjunctivitis sicca; dry eye disease; cyclosporine A; TOPICAL CYCLOSPORINE; OCULAR SURFACE; 0.05-PERCENT CYCLOSPORINE; EMULSION; 0.05-PERCENT; EFFICACY; SAFETY; 0.1-PERCENT; CLASSIFICATION; SUBCOMMITTEE; EPIDEMIOLOGY;

D O I：

10.2147/OPTH.S184412

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Dry eye disease (DED) is a multifactorial disease of ocular surface and tear film, and is a common disorder treated by eye care providers. It is well established that ocular surface inflammation has an important role in the pathophysiology of DED and that anti-inflammatory cyclosporine A (CsA) improves the treatment outcomes of most patients with DED. The purpose of this review is to provide guidance for practitioners in the use of topical CsA for the management of DED to improve patient satisfaction and the quality of life.

引用

页码：1115 / 1122

页数：8

共 54 条

[1] Modern approaches to the ocular delivery of cyclosporine A [J].

Agarwal, Priyanka ;

Rupenthal, Ilva D. .

DRUG DISCOVERY TODAY, 2016, 21 (06) :977-988

[2]

Allergan Inc., 2017, REST CYCL OPHTH EM 0

[3] Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years [J].

Barber, LD ;

Pflugfelder, SC ;

Tauber, J ;

Foulks, GN .

OPHTHALMOLOGY, 2005, 112 (10) :1790-1794

[4] Role of Hyperosmolarity in the Pathogenesis and Management of Dry Eye Disease: Proceedings of the OCEAN Group Meeting [J].

Baudouin, Christophe ;

Aragona, Pasquale ;

Messmer, Elisabeth M. ;

Tomlinson, Alan ;

Calonge, Margarita ;

Boboridis, Kostas G. ;

Akova, Yonca A. ;

Geerling, Gerd ;

Labetoulle, Marc ;

Rolando, Maurizio .

OCULAR SURFACE, 2013, 11 (04) :246-258

[5] TFOS DEWS II pathophysiology report [J].

Bron, Anthony J. ;

de Paiva, Cintia S. ;

Chauhan, Sunil K. ;

Bonini, Stefano ;

Gabison, Eric E. ;

Jain, Sandeep ;

Knop, Erich ;

Markoulli, Maria ;

Ogawa, Yoko ;

Perez, Victor ;

Uchino, Yuichi ;

Yokoi, Norihiko ;

Zoukhri, Driss ;

Sullivan, David A. .

OCULAR SURFACE, 2017, 15 (03) :438-510

[6] Efficacy of Combined 0.05% Cyclosporine and 1% Methylprednisolone Treatment for Chronic Dry Eye [J].

Byun, Yeo-jue ;

Kim, Tae-im ;

Kwon, Sang Min ;

Seo, Kyung Yul ;

Kim, Sun Woong ;

Kim, Eung Kweon ;

Park, Woo Chan .

CORNEA, 2012, 31 (05) :509-513

[7] Topical Cyclosporine Pretreatment of Ocular Surface in Allogeneic Hematopoietic Stem Cell Transplant Recipients [J].

Chun, Yoon Hong ;

Beak, Jin Uk ;

Kim, Hyun-Seung ;

Na, Kyung-Sun .

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2018, 34 (09) :628-632

[8] Interferon-γ-Induced Unfolded Protein Response in Conjunctival Goblet Cells as a Cause of Mucin Deficiency in Sjogren Syndrome [J].

Coursey, Terry G. ;

Henriksson, Johanna Tukler ;

Barbosa, Flavia L. ;

de Paiva, Cintia S. ;

Pflugfelder, Stephen C. .

AMERICAN JOURNAL OF PATHOLOGY, 2016, 186 (06) :1547-1558

[9] TFOS DEWS II Definition and Classification Report [J].

Craig, Jennifer P. ;

Nichols, Kelly K. ;

Akpek, Esen K. ;

Caffery, Barbara ;

Dua, Harminder S. ;

Joo, Choun-Ki ;

Liu, Zuguo ;

Nelson, J. Daniel ;

Nichols, Jason J. ;

Tsubota, Kazuo ;

Stapleton, Fiona .

OCULAR SURFACE, 2017, 15 (03) :276-283

[10] Estimated Prevalence and Incidence of Dry Eye Disease Based on Coding Analysis of a Large, All-age United States Health Care System [J].

Dana, Reza ;

Bradley, John L. ;

Guerin, Annie ;

Pivneva, Irina ;

Stillman, Ipek Ozer ;

Evans, Amber M. ;

Schaumberg, Debra A. .

AMERICAN JOURNAL OF OPHTHALMOLOGY, 2019, 202 :47-54

← 1 2 3 4 5 6 →